Covestor’s Teradyne TER Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$84K Buy
209
+52
+33% +$19.2K 0.05% 444
2026
Q2
$76K Sell
157
-81
-34% -$30.6K 0.04% 533
2026
Q1
$71K Sell
238
-511
-68% -$142K 0.05% 476
2025
Q4
$145K Sell
749
-426
-36% -$73.1K 0.08% 365
2025
Q3
$162K Sell
1,175
-212
-15% -$23.2K 0.09% 305
2025
Q2
$124K Buy
1,387
+485
+54% +$38.8K 0.07% 432
2025
Q1
$75K Buy
902
+1
+0.1% +$112 0.05% 657
2024
Q4
$113K Buy
901
+99
+12% +$11.7K 0.07% 447
2024
Q3
$108K Sell
802
-363
-31% -$48.9K 0.07% 478
2024
Q2
$173K Buy
1,165
+3
+0.3% +$381 0.11% 204
2024
Q1
$131K Buy
1,162
+108
+10% +$11.3K 0.08% 351
2023
Q4
$114K Buy
1,054
+78
+8% +$7.4K 0.08% 410
2023
Q3
$98K Sell
976
-92
-9% -$9.7K 0.07% 429
2023
Q2
$119K Buy
1,068
+136
+15% +$13.6K 0.09% 339
2023
Q1
$100K Sell
932
-170
-15% -$17.4K 0.09% 374
2022
Q4
$96K Buy
1,102
+115
+12% +$9.9K 0.08% 407
2022
Q3
$74K Buy
987
+68
+7% +$6.2K 0.07% 526
2022
Q2
$82K Buy
919
+199
+28% +$20.7K 0.07% 519
2022
Q1
$85K Buy
720
+155
+27% +$19.6K 0.06% 609
2021
Q4
$92K Buy
+565
New +$79.5K 0.13% 206

Other funds holding TER

Covestor's TER Position: Q3 2026 in Review

Covestor increased its Teradyne (TER) stake by 33% in Q3 2026, buying an estimated $19.2K and bringing the position to 209 shares worth $84K. The position accounts for 0.05% of the portfolio, ranked #444.

Covestor first reported a position in TER in Q4 2021 and has held it in 20 quarters since. The position peaked at $173K in Q2 2024. 484 funds tracked by Wall St. Rank hold TER as of Q3 2026.

  • Covestor held 209 shares of Teradyne worth $84K as of Q3 2026.
  • Covestor bought 52 Teradyne shares in Q3 2026, an estimated $19.2K.
  • Teradyne made up 0.05% of Covestor's portfolio in Q3 2026, its #444 holding.
  • Covestor first reported a position in Teradyne in Q4 2021 and has held it in 20 quarters since.
  • Covestor's Teradyne position peaked at $173K in Q2 2024.
  • 484 funds tracked by Wall St. Rank held Teradyne as of Q3 2026.

Based on Covestor's 13F filing for Q3 2026, filed 30 Oct 2026.